Abstract
Introduction

27
RNA editing is a widely conserved and pervasive method of mRNA modification in which the 28 sequence of a mRNA is altered from that encoded by the DNA (Nishikura, 2016; Walkley and Li, 29 2017) . In mammals, the most prevalent type of RNA editing is Adenosine-to-Inosine (A-to-I)
30
RNA editing (Eisenberg and Levanon, 2018) . After editing occurs, inosine is recognized by the 31 cellular machinery as guanosine (G); therefore, the editing of a nucleotide can have a variety of 32 effects, including altering RNA processing, changing splice sites, and expanding the coding 
150
Overall, we found many more candidates specific to ADAR2 than ADAR1, which is likely due to 151 the fact that ADAR2-BirA* was more highly expressed than ADAR1-BirA*; we found that 152 overexpressed ADAR2 consistently accumulates to higher protein levels than overexpressed 153 ADAR1, perhaps reflecting different mechanisms of regulation (data not shown). We also found 154 a large number of cell-type-specific ADAR interactors (118 M17 versus 127 HeLa hits), which
155
we hypothesized might be differentially expressed between the two cell types. To determine 156 whether cell-type-specific interactors were more highly expressed in the cell type in which they RNA-seq. We found that candidates specific to M17 cells were more highly expressed in M17 
169
BioID altered editing levels. We found that knockdown of 8 of the 19 proteins profiled by 170 ENCODE resulted in increases or decreases in the editing levels of more than 100 sites, while 171 the remaining 11 affected a smaller more specific set of sites (Figure 2A, 2S 
184
RNA at or near editing sites, we compared the positions of their binding sites to the editing sites 185 that they regulated to determine whether their knockdown affected editing levels specifically at 186 the sites that were bound by the proteins. We found a statistical enrichment for 11 of the 13 187 candidates indicating that they changed editing levels at editing sites near where they bound 188 RNA, suggesting a direct role in RNA editing ( Figure 2E) . Of those proteins, only U2AF2 and
189
XRCC6 altered the majority of known editing sites in a single direction (Figure 2A,E 
229
We also wanted to interrogate the reciprocal condition, the ability of each candidate to 
255
We choose to perform these experiments in HEK293T cells both because in contrast to M17 
296
HEK293T-ADAR2-OE cells. We found that ADAR1 mRNA and protein levels were largely 297 unchanged ( Figure S7A, B) . ADAR2 transcript levels were reduced, which may account for 298 some of the editing effects in HEK293T-ADAR2-OE cells ( Figure S8A, B) 
313
then the ability of ILF3 to affect editing levels would be dependent on its ability to bind RNA. To 314 test this hypothesis, we overexpressed a FLAG-tagged mutant of ILF3 that lacks its two 315 dsRBDs (Δ402-572) in HEK293T and HEK293T-ADAR2-OE cells ( Figure 5A , B, S9A, Table   316 S1). In both cases, ILF3-ΔdsRBD-OE did not induce a global reduction in editing ( Figure 5C , 317 S9B), suggesting that ILF3's RNA binding ability is necessary for its regulation of editing levels.
318
In addition, we performed a FLAG IP to pull down the mutant and wild-type version of ILF3 and 319 found that only wild-type ILF3 interacts with ADAR1 and ADAR2 ( Figure 5D ). This result further 320 supports the hypothesis that it is the ability of ILF3 to bind RNA and compete for substrates with
321
ADARs that regulates editing levels. 
337
ADAR proteins in a cell-type-specific context that may not exist in our system. While many 338 proteins were found in multiple BioID conditions, supporting the reproducibility and robustness 339 of this approach, we also uncovered numerous cell-type-specific and ADAR1-or ADAR2-340 specific interactors. Cell-type-specific hits may arise from differences in expression of those 341 proteins between cell types, however a similar explanation would not explain ADAR-specific 342 hits. We cannot rule out that some of the proteins specific to each condition may be an artifact 
352
When we first set out to identify trans regulators of editing, we were investigating two major 353 potential mechanisms that could account for the observed tissue-specific differences in editing.
354
Trans regulators could act directly on ADAR proteins to modify their activity at all sites equally 
423
BirA* constructs (BirA*-ADAR1, BirA*-ADAR2, BirA*-GFP) were created by subcloning the 424 cDNA for each gene into the pCDH backbone containing a 3XFLAG tag, a nuclear localization
425
sequence and the BirA* cDNA sequence upstream of the target gene, resulting in 3xFLAG-NLS-
426
BirA*-ADAR1, 3xFLAG-NLS-BirA*-ADAR2, and 3xFLAG-NLS-BirA*-GFP constructs and, when 427 translated, fusion proteins. These constructs were used to generate lentivirus, as described 
515
Phenomenex, Torrance, CA) was packed in-house from particle slurries in methanol 2.5 cm. An 516 additional 2.5 cm reversed phase particles (C18 Aqua, 3 µm dia., 125 Å pores, Phenomenex)
517
were then similarly packed into the capillary using the same method as SCX loading, to create a 
543
Peptide candidates were filtered using DTASelect, with these parameters -p 2 -y 2 --trypstat --pfp 544
0.01 --extra --pI -DM 10 --DB --dm -in -m 1 -t 1 --brief --quiet (1, 3).
546
Analysis of BioID hits
BirA*-ADAR1 and BirA*-ADAR2 experiments were analyzed separately. 
612
For both RNA-seq and mmPCR-seq analysis, any variability between replicates could arise for a 613 number of reasons, e.g. low expression or inefficient primer-based amplification, so for all subsequent analyses we only assessed sites with high coverage (50X in mmPCR-seq and 20X
615
in RNA-seq) that were <10% different between replicates (Figure S6A, B) .
617
For gene expression analysis, FPKMs were calculated using RSEM 
632
Lucigen H39500) to make 10 ul total and incubated for 30 minutes at 45C. rRNA-depleted RNA
633
was then purified using 2.2X reaction volume of Agencourt RNAClean XP beads (Beckman
634
Coulter: A63987), treated with TURBO DNase (Invitrogen: AM1907), and then purified with
635
RNAClean XP beads again. rRNA-depleted RNA was used as input to the KAPA HyperPrep
636
RNA-seq Kit (Kapa Biosystems: KK8540). All libraries were sequenced with 76 base-pair 637 paired-end reads using an Illumina NextSeq (Illumina, San Diego, CA).
639
Sanger Sequencing of RNA levels
640
To determine editing levels at PAICS and GRIA2 editing sites, RNA was extracted from M17 641 cells expressing BirA*-GFP, BirA*-ADAR1, and BirA*-ADAR2 using Zymo Quick RNA kit. RNA
642
was treated with TURBO DNase and then cDNA was synthesized using Bio-Rad iScript
643
Advanced cDNA synthesis kit. PCR was performed using the following to amplify around the 
648
Two replicates were performed for each group of cells.
650
ENCODE data analysis
651
We downloaded the mapped BAM files (HG38 version) of RNA-seq data generated following
652
RBP knockdown or control shRNA transfection from the ENCODE data portal
653
(encodeproject.org). For the RNA-seq data, we used the same pipeline as described in the
654
Analysis of mmPCR-seq and RNA-seq section to quantify editing levels. Similarly, as reported 
663
To determine where the RBPs bind on the RNA, we analyzed the eCLIP-seq data from 
